A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability, and Population Pharmacokinetics of LCB01-0371 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Nov 2014
At a glance
- Drugs LCB01-0371 (Primary)
- Indications Bacterial infections; Gram-positive infections
- Focus Adverse reactions
- Sponsors LegoChem Biosciences
- 16 Nov 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 06 May 2013 New trial record